Publication | Open Access

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals

Preventive MedicineHealth PolicyHealth EconomicsCardiovascular DiseaseRandomised TrialClinical TrialsEconomic AnalysisPharmacoeconomicsHealth Care CostCost EffectivenessDifferent LevelsPublic HealthEconomic EvaluationMedicineAtherosclerosisEpidemiology